Assembly Biosciences Inc (NASDAQ:ASMB)
| 1.33 Delayed Data As of Dec 02 |  +0.01 / +0.77%Today’s Change | 1.20 Today|||52-Week Range 2.45 | -42.92% Year-to-Date |
Latest ASMB News | Press Releases
No recent news for Assembly Biosciences Inc.
Today’s Trading
| Previous close | 1.30 |
| Today’s open | 1.27 |
| Day’s range | 1.27 - 1.35 |
| Volume | 165,951 |
| Average volume (3 months) | 234,267 |
| Market cap | $64.4M |
Data as of 3:59pm ET, 12/02/2022
Growth & Valuation
| Earnings growth (last year) | -71.02% |
| Earnings growth (this year) | +41.33% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | -92.09% |
| P/E ratio | NM |
| Price/Sales | 16.12 |
| Price/Book | 0.38 |
Competitors
Data as of 3:59pm ET, 12/02/2022
Financials
| Next reporting date | March 9, 2023 |
| EPS forecast (this quarter) | -$0.40 |
| Annual revenue (last year) | $6.3M |
| Annual profit (last year) | -$129.9M |
| Net profit margin | -2,076.35% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
